Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) Sees Large Volume Increase – Here’s What Happened

Shares of Telix Pharmaceuticals Limited American Depositary Shares (NASDAQ:TLX) saw strong trading volume on Monday . 64,083 shares traded hands during trading, an increase of 146% from the previous session’s volume of 26,033 shares.The stock last traded at $18.12 and had previously closed at $18.40.

Wall Street Analysts Forecast Growth

TLX has been the subject of a number of analyst reports. UBS Group lifted their target price on shares of Telix Pharmaceuticals Limited American Depositary Shares from $21.00 to $22.00 and gave the company a “buy” rating in a research note on Monday, January 27th. William Blair reaffirmed an “outperform” rating on shares of Telix Pharmaceuticals Limited American Depositary Shares in a research note on Wednesday.

Telix Pharmaceuticals Limited American Depositary Shares Price Performance

The business’s fifty day moving average is $17.35.

About Telix Pharmaceuticals Limited American Depositary Shares

Telix Pharmaceuticals Ltd. engages in the development and commercialization of several clinical-stage oncology assets. It operates through the following segments: Commercial, Product Development, and Group and Unallocated. The Commercial segment includes sales of Illuccix and other products subsequent to obtaining regulatory approvals.